Kusurinomadoguchi, Inc. (JP:5592)
:5592
Want to see JP:5592 full AI Analyst Report?
5592 Stock Chart & Stats
¥2661.00
-¥9.00(-0.63%)
At close: 4:00 PM EST
¥2661.00
-¥9.00(-0.63%)
Day’s Range― - ―
52-Week Range¥2,315.00 - ¥4,685.00
Previous CloseN/A
Volume47.70K
Average Volume (3M)73.92K
Market Cap
¥32.66B
Enterprise Value¥29.30B
Total Cash (Recent Filing)¥1.89B
Total Debt (Recent Filing)¥56.01M
Price to Earnings (P/E)9.3
Beta0.77
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.03%
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,458,582
10 Day Avg. Volume72,500
30 Day Avg. Volume73,916
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.41
Price to Sales (P/S)2.22
P/FCF Ratio9.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue & Earnings GrowthSustained multi-year top-line and net income expansion indicates durable demand and scalable unit economics. Persistent revenue and profit growth supports reinvestment in the platform, improves ability to fund marketing and tech, and creates a structural base for margin expansion and strategic optionality.
Digital-first Online Pharmacy ModelA digital mediation model linking patients, pharmacists and providers is structurally advantaged by low incremental distribution costs and recurring fee opportunities. This model scales with customer acquisition, fosters partnerships, and aligns with long-term trends toward telehealth and convenience-driven pharma access.
Strengthened Equity BaseMaterial equity growth improves solvency and financial flexibility, enabling investment and acquisition optionality without immediate refinancing pressure. Attractive reported ROE levels suggest efficient use of capital when profitable, supporting sustainable capacity to fund strategic growth initiatives.
Bears Say
Large Cash-flow Outflow In 2025A major negative cash-flow year undermines earnings quality and indicates significant working-capital or investment swings. Such episodes can force external financing, strain liquidity, and reduce predictability of cash available to sustain operations or fund growth, creating structural execution risk.
Volatile Balance-sheet MetricsSharp asset and debt swings signal irregular financing, disposals, or large one-off items that reduce predictability. This volatility complicates capacity planning, credit assessments and covenants, and increases execution risk for multi-year strategies reliant on stable capital structure.
Limited Visibility Into Recent Margin CompositionAbsent up-to-date margin breakdowns and with inconsistent growth metrics, it is harder to assess sustainability of profitability improvements. This opacity limits confidence in whether earnings gains are structural (pricing, unit economics) or transitory (one-offs, timing effects), raising forecasting risk.
Kusurinomadoguchi, Inc. News
5592 FAQ
What was Kusurinomadoguchi, Inc.’s price range in the past 12 months?
Kusurinomadoguchi, Inc. lowest stock price was ¥2315.00 and its highest was ¥4685.00 in the past 12 months.
What is Kusurinomadoguchi, Inc.’s market cap?
Kusurinomadoguchi, Inc.’s market cap is ¥32.66B.
When is Kusurinomadoguchi, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kusurinomadoguchi, Inc.’s earnings last quarter?
Currently, no data Available
Is Kusurinomadoguchi, Inc. overvalued?
According to Wall Street analysts Kusurinomadoguchi, Inc.’s price is currently Overvalued.
Does Kusurinomadoguchi, Inc. pay dividends?
Kusurinomadoguchi, Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 1.03%. See more information on Kusurinomadoguchi, Inc. dividends here
What is Kusurinomadoguchi, Inc.’s EPS estimate?
Kusurinomadoguchi, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kusurinomadoguchi, Inc. have?
Kusurinomadoguchi, Inc. has 11,458,582 shares outstanding.
What happened to Kusurinomadoguchi, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kusurinomadoguchi, Inc.?
Currently, no hedge funds are holding shares in JP:5592
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kusurinomadoguchi, Inc.
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmacies; site for medicine counter telephone medical treatment; Health Tech Navi, an electronic medication history system; Care Daisy system to link recording systems and ICT devices; solution for purchasing pharmaceuticals; and system that allows for centralized management of outpatient reception, outpatient reservations, and online medical treatment. It also provides Pharmacy Support, a customer management system for repeat patients in the pharmacy industry; system specialized for dispensing pharmacies; matching service that connects nursing care facilities and pharmacies; solution from the purchase of pharmaceuticals to the purchase of immovable inventory; Online consultation by hospital support; online medication guidance; support solution to pharmacies; EPARK medicine notebook, a medication notebook that allows to make dispensing reservations and manage family medicines; and a system that allows patients to select the pharmacy they want to visit. The company was founded in 2004 and is headquartered in Tokyo, Japan.
Technical Analysis
Options Prices
Currently, No data available
---